<DOC>
	<DOCNO>NCT00953771</DOCNO>
	<brief_summary>The purpose study find administration danazol plasma exchange corticosteroid reduce number plasma exchange require control Thrombotic Thrombocytopenic Purpura ( TTP ) .</brief_summary>
	<brief_title>Safety Study Danazol With Plasma Exchange Steroids Treatment Thrombotic Thrombocytopenic Purpura ( TTP )</brief_title>
	<detailed_description>Danazol synthetic steroid hormone structurally resemble group natural hormone ( androgen ) find body . Danazol immune modifying activity effective treatment blood disorder low platelet count idiopathic thrombocytopenic purpura ( however FDA yet approve danazol disorder ) . A study danazol conjunction plasma exchange thrombotic thrombocytopenic purpura show danazol decrease number plasma exchange require approximately 80 % reduced time need control disease . It 's clear danazol work TTP . It approve FDA treatment TTP .</detailed_description>
	<mesh_term>Purpura , Thrombocytopenic</mesh_term>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Purpura , Thrombotic Thrombocytopenic</mesh_term>
	<mesh_term>Danazol</mesh_term>
	<criteria>TTP platelets less 10,000 microangiopathic hemolytic anemia Age great 18 less 60 LDH &gt; 2x upper limit normal PT PTT normal Patients must give sign informed consent Premenopausal woman must negative pregnancy test . TTP related underlying cancer , treatment cancer transplantation . TTP associate drug . LFTs AST/ALT &gt; 2x upper limit normal Hepatitis B Hepatitis C infection . HIV active opportunistic infection Acute chronic Disseminated Intravascular Coagulation ( DIC ) , define Ddimer 8ug/ml fibrinogen &lt; 100 mg/dl TTP relate drug , malignancy transplantation . Pregnancy Concurrent investigational drug use study . Porphyria .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>TTP</keyword>
	<keyword>Thrombotic Thrombocytopenic Purpura</keyword>
</DOC>